Willems Hubertine M E, Bruner Winter S, Barker Katherine S, Liu Junyan, Palmer Glen E, Peters Brian M
Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA
Infect Immun. 2017 Sep 20;85(10). doi: 10.1128/IAI.00248-17. Print 2017 Oct.
The secreted aspartyl proteinases of have long been implicated in virulence at the mucosal surface, including contributions to colonization and immunopathogenesis during vulvovaginal candidiasis. In an effort to disentangle hypha-associated virulence factor regulation from morphological transition, the purpose of this study was to determine if overexpression of or in an Δ/Δ Δ/Δ mutant could restore the capacity to cause immunopathology during murine vaginitis to this avirulent hypofilamentous strain. Two similar yet distinct genetic approaches were used to construct expression vectors to achieve SAP overexpression, and both genetic and functional assays confirmed elevated SAP activity in transformed strains. Similar to previous findings, intravaginal challenge of C57BL/6 mice with hypha-defective strains attained high levels of mucosal colonization but failed to induce robust vaginal immunopathology (neutrophil recruitment, interleukin-1β [IL-1β] secretion, and lactate dehydrogenase release) compared to that with the hypha-competent control. Moreover, constitutive expression of or in two distinct sets of such strains did not elicit immunopathological markers at levels above those observed during challenge with isogenic empty vector controls. Therefore, these results suggest that the physiological contributions of SAPs to vaginal immunopathology require hypha formation, other hypha-associated factors, or genetic interaction with and/or to cause symptomatic infection. Additionally, the outlined expression strategy and strain sets will be useful for decoupling other downstream morphogenetic factors from hyphal growth.
长期以来,白色念珠菌分泌的天冬氨酸蛋白酶一直被认为与黏膜表面的毒力有关,包括在念珠菌性外阴阴道炎期间对定植和免疫发病机制的作用。为了将与菌丝相关的毒力因子调节与形态转变区分开来,本研究的目的是确定在Δ/Δ Δ/Δ突变体中过表达或是否能恢复这种无毒的菌丝稀少菌株在小鼠阴道炎期间引起免疫病理的能力。我们使用了两种相似但不同的基因方法来构建表达载体以实现天冬氨酸蛋白酶的过表达,并且基因和功能检测均证实转化菌株中的天冬氨酸蛋白酶活性升高。与先前的研究结果相似,与具有菌丝形成能力的对照相比,用菌丝缺陷菌株对C57BL/6小鼠进行阴道攻击可实现高水平的黏膜定植,但未能诱导强烈的阴道免疫病理反应(中性粒细胞募集、白细胞介素-1β[IL-1β]分泌和乳酸脱氢酶释放)。此外,在两组不同的此类菌株中组成型表达或并没有引发高于同基因空载体对照攻击期间观察到水平的免疫病理标志物。因此,这些结果表明,天冬氨酸蛋白酶对阴道免疫病理的生理作用需要菌丝形成、其他与菌丝相关的因子,或与和/或的基因相互作用才能引起有症状的感染。此外,所概述的表达策略和菌株组将有助于将其他下游形态发生因子与菌丝生长解耦。